Ruxolitinib for chronic steroid-refractory graft versus host disease: a single center experience
Elisabetta Xue, Francesca Lorentino, Francesca Pavesi, Andrea Assanelli, Jacopo Peccatori, Massimo Bernardi, Consuelo Corti, Fabio Ciceri, Maria Teresa Lupo Stanghellini
Topics & Concepts
RuxolitinibMedicineDiscontinuationGraft-versus-host diseaseInternal medicineAdverse effectSingle CenterHematopoietic stem cell transplantationCohortRetrospective cohort studySurgeryGastroenterologyTransplantationBone marrowMyelofibrosisHematopoietic Stem Cell TransplantationSystemic Sclerosis and Related DiseasesMyeloproliferative Neoplasms: Diagnosis and Treatment